3 ms·
>Almost all the cost in a drug is the manufacturer recouping R&D costs. Actually that's not true. Big pharma spends twice as much on advertising as they do on
by Alex3917 15y ago
>Almost all the cost in a drug is the manufacturer recouping R&D costs.
Actually that's not true. Big pharma spends twice as much on advertising as they do on R&D:
http://www.sciencedaily.com/releases/2008/01/080105140107.htm http://www.sciencedaily.com/releases/2008/01/080105140107.ht...
They also spend a significant amount of money on government fines due to corrupt practices (i.e. killing people). They are now the single most corrupt industry, paying significantly more fines per year than the entire military industrial complex:
http://www.citizen.org/hrg1924 http://www.citizen.org/hrg1924
- mjallday 15y agoIs paying fines corrupt? I would say that dodging fines would be considerably more corrupt.
- man1sh 15y agoThey pay fines for their corrupt behavior. You understood it wrong
- liber8 15y agoSimply because you are forced to pay fines doesn't mean you are "corrupt". The abstract indicates most of the fines come from "illegal off-label drug promotion" and "overcharging state governments". It could be argued that the first shouldn't even be an issue, and the second, depending on how "overcharging" is defined could be outright fraud on the part of big pharma, fraud on the part of state governments, or something in between.
- makmanalp 15y agoI'll play devil's advocate: Marijuana users pay fines too, are they also corrupt and immoral? How about drivers who drive at 80km/h on a highway that is 95% 80km/h and 5% 50km/h which was obviously set up to trap people into paying fees? How do you know the fees that big pharma pays are not because of similar over-oppressive laws designed to make the government money? Edit: Well, I'm a moron for talking before reading. Scratch that.
- Alex3917 15y ago"How do you know the fees that big pharma pays are not because of similar over-oppressive laws designed to make the government money?" Because I read the study.
- JunkDNA 15y agoIf you took the time to look at the link I posted that talks about the Forbes piece, you'd see that they specifically excluded the cost of marketing from the analysis of how much it costs to put out a new drug. When companies do marketing, they expect it to more than pay for itself, clearly it is, or they wouldn't be spending so much on it. I know people don't like to hear it, but marketing products does lead to more sales. Trust me, having worked in an R&D organization, there was no want for more funding. There was an incredible level of funding. If the problem in the drug industry is simply that not enough is being spent on R&D, that is easily correctable. Unfortunately for all of us, that's not the problem.
- Alex3917 15y ago"If the problem in the drug industry is simply that not enough is being spent on R&D, that is easily correctable. Unfortunately for all of us, that's not the problem." The problem with the drug industry is basically that many of their most important epistemological assumptions are largely incorrect. The reason the entire industry is about to go under isn't because all the easy cures have been taken, it's because they started to buy into their own bullshit. Their astronomical R&D costs and terrible success rates are largely their own fault, so I don't really buy this high cost of R&D argument as a reason for not making the drugs more widely available. I won't bother rehashing all of the epistemological problems with allopathic medicine here, but I was link to this video which talks about why the ubiquitous mouse model is so problematic: http://vimeo.com/33803995 http://vimeo.com/33803995 Plus, many of the new drugs are just evergreens, so much of that 'R&D' is really just a clever way to screw the patients.
- thwest 15y agoOf course one expects marketing mental diseases to be effective! 'Its not your fault, take a pill and it will all go away' certainly has mass emotional appeal. However, the article is not too convincing about the methodology of excluding marketing expenses. First - and I know that I'm going to hear about this from some people - you might assume that different companies are putting different things under the banner of R&D for accounting purposes. But there's a limit to how much of that you can do. Remember, there's a separate sales and marketing budget, too, of course, and people never get tired of pointing out that it's even larger than the R&D one. So how inflated can these figures be? Not particularly powerful evidence here: a vague notion of a limit, and a rhetorical question. Corporate accounting statements are generally only accountable to the board of directors, who might be perfectly happy with pushing the limit on creative accounting while the stock goes up. When aimed at investors other than the board, and especially when used by citizens attempting to assess the social value of institutions, accounting statements are better treated as marketing materials themselves. We can discuss evidence when the CFOs of these corporations open their daily work to a public VNC session.
- InclinedPlane 15y agoKeep in mind that the majority of the cost that gets put under the "advertising" label is actually free samples. Those effectively lower the cost of care for patients, it's not just money spent on madison avenue.
- DanBC 15y agoThere's no need for free samples in the UK[1], there's no direct marketing to patients, and yet we had to pass laws to stop marketing aimed at doctors. Pharmaceutical companies were spending around £10,000 per GP per year. (About 40,000 GPs in UK * £10,000 == £400,000,000) Because of our PPRS that figure is probably one of the lowest in Europe. The UK spends about £11billion per year on medication. Of that about £8billion is spent on branded medication. We have regulation schemes aimed at driving costs down. The market and regulation of medication is baffling with many hidden effects. Here's some ridiculously in-depth information about the UK Pharmaceutical Price Regulation Scheme, and about regulation of meds in Europe. (http://www.euro.who.int/__data/assets/pdf_file/0008/98432/E83015.pdf http://www.euro.who.int/__data/assets/pdf_file/0008/98432/E8...) (http://www.oft.gov.uk/shared_oft/reports/comp_policy/oft885.pdf http://www.oft.gov.uk/shared_oft/reports/comp_policy/oft885....) [1] - because any medication is only £7.40 per item (per month) and only about 15% of people need to pay because of all the exemptions. Also, because of the pay structure of prescriptions there's a split between doctors (who write prescriptions) and pharmacists (who earn money for dispensing).